β-Carbolines: New Insights into the Clinical Pharmacology of Benzodiazepine Receptor Ligands
- 1 January 1987
- book chapter
- Published by Springer Nature
- Vol. 3, 37-51
- https://doi.org/10.1007/978-3-642-71288-3_5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Ligands for benzodiazepine receptors with positive and negative efficacyBiochemical Pharmacology, 1984
- CGS 9896: A nonbenzodiazepine, nonsedating potential anxiolyticDrug Development Research, 1984
- Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788Psychopharmacology, 1983
- RO 15-1788 antagonises the central effects of diazepam in man without altering diazepam bioavailability.British Journal of Clinical Pharmacology, 1982
- Interaction of Convulsive Ligands with Benzodiazepine ReceptorsScience, 1982
- CGS 8216: Receptor binding characteristics of a potent benzodiazepine antagonistLife Sciences, 1982
- REVERSAL OF BENZODIAZEPINE-INDUCED SEDATION BY INTRAVENOUS Ro 15-1788The Lancet, 1981
- Proconvulsant effects in baboons of β-carboline, a putative endogenous ligand for benzodiazepine receptorsNeuroscience Letters, 1981
- Ethyl β-carboline carboxylate lowers seizure threshold and antagonizes flurazepam-induced sedation in ratsNature, 1981
- Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.Proceedings of the National Academy of Sciences, 1980